MedPath

Vitamin B12 Pregnancy Supplementation

Phase 4
Completed
Conditions
Pregnancy Anemia
Interventions
Dietary Supplement: vitamin b12
Registration Number
NCT03522428
Lead Sponsor
Mirela Zec
Brief Summary

Pregnancy is associated with increased requirements for iron and increased blood volume of up to 40%. Because expansion in plasma volume is higher than the increase in the mass of red blood cells, there is a fall in hemoglobin concentration, which leads to physiological anemia, characterized with lower hemoglobin (Hb), hematocrit and red blood cells, but without changes in mean corpuscular volume (MCV). Anemia in pregnancy is defined with Hb values under 110 g/L in the first trimester and under 105 g/L in the second and third trimester.

Iron deficiency is thought to be the most common nutrient deficiency among pregnant women. Consequences of anemia include delayed fetal growth, premature delivery, intrauterine fetal death, postpartum depression and delayed psychomotor development of a child. It is known that in women that are not anemic daily iron supplementation of 27 mg/day is sufficient, which can be obtained from adequate nutrition or body supplies. Iron supplementation is pregnancy has been recommended by the WHO (World Health Organisation) since 1959, and this recommendation was confirmed by numerous professional associations. However, in women with anemia, or women subjected to particular dietary regimens with diminished quantity of iron, including vegetarian or vegan diet, required supplementation dosage is higher, and estimated in the literature to be 120 mg/day.

The aim of this study was to analyze whether adding vitamin B12 (5 µg /100 days), along with folic acid and iron as supplement in pregnant women who are not anemic and who need only iron supplementation, will result in improvements of hematological and biochemical markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • healthy women from 8th week of pregnancy
Exclusion Criteria
  • existence of hypertension
  • existence of diabetes
  • existence of genetic abnormalities
  • smoking
  • previous miscarriage

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Receiving treatmentvitamin b12Adding vitamin B12 at a dose of 5 μg / 100 days, custom folic acid therapy and iron supplements
Primary Outcome Measures
NameTimeMethod
Change of Red blood cells (RBC) count in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

RBC count measured in SI (Systeme International) units (Nx10\*12/L)

Change of Hemoglobin (Hgb) concentration in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

Hgb concentration in SI units (g/L)

Change of Hematocrit in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

volume percentage (%)

Change of Mean corpuscular volume (MCV) in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

mean volume of red blood cells in SI units (fL)

Change of Mean corpuscular hemoglobin concentration (MCHC) in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

Average hemoglobin concentration in a given volume of packed RBCs i SI units (g/L)

Change of Mean corpuscular hemoglobin (MCH) in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

average weight of hemoglobin in an average red blood cell in SI units (pg)

Change of Iron (Fe) in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

non-heme iron in serum in SI units (µmol/L)

Change of Haptoglobin in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

concentration of free haptoglobin in serum in SI units (g/L)

Change of Ferritin in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

serum ferritin in SI units (µg/L)

Change of Total Iron Binding Capacity (TIBC) in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

total iron binding capacity in SI units (µmol/L)

Change of Unsaturated Iron Binding Capacity (UIBC) in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

unsaturated iron binding capacity in SI units (µmol/L)

Secondary Outcome Measures
NameTimeMethod
Change of White Blood Cells (WBC) in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

RBC count measured in SI units (Nx10\*9/L)

Change of Platelet Count in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

RBC count measured in SI units (Nx10\*9/L)

Change of Transferrin in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

transferrin serum concentration in SI units (g/L)

Change of Neutrophils in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

proportion of neutrophils of all white cells (%)

Change of Lymphocytes in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

proportion of lymphocytes of all white cells (%)

Change of Monocytes in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

proportion of monocytes of all white cells (%)

Change of Eosinophils in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

proportion of eosinophils of all white cells (%)

Change of Basophils in first and second trimesterat two time points: on the 8th-10th and 22nd-24th weeks of pregnancy

proportion of basophils of all white cells (%)

© Copyright 2025. All Rights Reserved by MedPath